Brief: Cosmos Health Actively Exploring Spinoff Of R&D Division Into A Publicly Listed Standalone Biotech Company
27/09/2023 15:48
Sept 27 (Reuters) - Cosmos Health Inc COSM.O :
* COSMOS HEALTH ACTIVELY EXPLORING SPINOFF OF RESEARCH AND
DEVELOPMENT DIVISION INTO A PUBLICLY LISTED STANDALONE BIOTECH
COMPANY
Source text for Eikon: ID:
Further company coverage: COSM.O
Recent news on Cosmos Health
See all newsCosmos Health Q3 revenue rises to record high on contract manufacturing
Brief: Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar
Brief: Cosmos Health Reaffirms 2029 Guidance
Brief: Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare
Brief: Cosmos Health Reports Q2 2026